Log in

NASDAQ:IRTCIrhythm Technologies Stock Price, Forecast & News

$113.50
-1.17 (-1.02 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$113.02
Now: $113.50
$119.66
50-Day Range
$109.59
MA: $121.57
$131.18
52-Week Range
$56.24
Now: $113.50
$136.55
Volume389,279 shs
Average Volume399,158 shs
Market Capitalization$3.07 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.41
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Its Zio XT monitor, a single-use, wire-free, and wearable patch-based biosensor, records patient's heartbeats and ECG data. The company was founded in 2006 and is headquartered in San Francisco, California.
Read More
Irhythm Technologies logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.39 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:IRTC
CUSIPN/A
Phone415-632-5700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$214.55 million
Book Value$5.09 per share

Profitability

Net Income$-54,570,000.00

Miscellaneous

Employees748
Market Cap$3.07 billion
Next Earnings Date7/29/2020 (Estimated)
OptionableOptionable

Receive IRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.

Irhythm Technologies (NASDAQ:IRTC) Frequently Asked Questions

How has Irhythm Technologies' stock been impacted by COVID-19 (Coronavirus)?

Irhythm Technologies' stock was trading at $85.54 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, IRTC shares have increased by 32.7% and is now trading at $113.50. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Irhythm Technologies?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Irhythm Technologies in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Irhythm Technologies.

When is Irhythm Technologies' next earnings date?

Irhythm Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Irhythm Technologies.

How were Irhythm Technologies' earnings last quarter?

Irhythm Technologies Inc (NASDAQ:IRTC) posted its earnings results on Thursday, May, 7th. The company reported ($0.34) EPS for the quarter, topping the Zacks' consensus estimate of ($0.57) by $0.23. The firm had revenue of $63.50 million for the quarter, compared to analysts' expectations of $61.40 million. Irhythm Technologies had a negative net margin of 24.34% and a negative return on equity of 49.99%. The firm's revenue for the quarter was up 35.1% compared to the same quarter last year. During the same period last year, the firm posted ($0.33) EPS. View Irhythm Technologies' earnings history.

What guidance has Irhythm Technologies issued on next quarter's earnings?

Irhythm Technologies issued an update on its first quarter 2020 After-Hours earnings guidance on Thursday, April, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $61-62 million, compared to the consensus revenue estimate of $60.67 million.

What price target have analysts set for IRTC?

8 equities research analysts have issued 1 year target prices for Irhythm Technologies' shares. Their forecasts range from $112.00 to $142.00. On average, they anticipate Irhythm Technologies' share price to reach $130.67 in the next year. This suggests a possible upside of 15.1% from the stock's current price. View analysts' price targets for Irhythm Technologies.

Has Irhythm Technologies been receiving favorable news coverage?

News headlines about IRTC stock have trended somewhat negative on Saturday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Irhythm Technologies earned a coverage optimism score of -1.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next few days. View the latest news about Irhythm Technologies.

Who are some of Irhythm Technologies' key competitors?

What other stocks do shareholders of Irhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Irhythm Technologies investors own include Alibaba Group (BABA), NVIDIA (NVDA), DexCom (DXCM), Paypal (PYPL), Teladoc Health (TDOC), Shopify (SHOP), Veeva Systems (VEEV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Paycom Software (PAYC).

Who are Irhythm Technologies' key executives?

Irhythm Technologies' management team includes the following people:
  • Mr. Kevin M. King, Pres, CEO & Director (Age 63)
  • Mr. Matthew C. Garrett, Chief Financial Officer (Age 51)
  • Mr. David A. Vort, Exec. VP of Sales (Age 53)
  • Dr. Derrick Sung, Exec. VP of Strategy & Corp. Devel. (Age 46)
  • Mr. Karim Karti, Chief Operating Officer (Age 50)

When did Irhythm Technologies IPO?

(IRTC) raised $76 million in an initial public offering (IPO) on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is Irhythm Technologies' stock symbol?

Irhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

How do I buy shares of Irhythm Technologies?

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Irhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $113.50.

How big of a company is Irhythm Technologies?

Irhythm Technologies has a market capitalization of $3.07 billion and generates $214.55 million in revenue each year. The company earns $-54,570,000.00 in net income (profit) each year or ($2.16) on an earnings per share basis. Irhythm Technologies employs 748 workers across the globe.

What is Irhythm Technologies' official website?

The official website for Irhythm Technologies is www.irhythmtech.com.

How can I contact Irhythm Technologies?

Irhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The company can be reached via phone at 415-632-5700 or via email at [email protected]

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.